Soaring prescription drug costs are a life-threatening concern
for Americans across the country.
Prices for medicine have skyrocketed in the past few years,
rising by 10 percent every year.
And because Medicare pays for most Americans’ care, these costs
directly affect government spending, costing American taxpayers billions of
dollars every year.
It’s time to fix this mess.
That’s why we have introduced the Creates Act, a commonsense bill to
reduce prescription prices for hardworking Americans.
The Creates Act is this solution. This bipartisan legislation
will aggressively lower drug prices through generic competition while ensuring
that the relevant safety protocols are in place for new generic drugs.
Reports by the Federal Trade Commission (FTC) and the Food and
Drug Administration (FDA) show that generic competition saves Americans
billions of dollars every year by reducing the price of branded drugs by more
than 85 percent.
But some branded drug companies have blocked generic competitors
from entering the market through delay tactics designed to keep prescription
drugs prices artificially high. One of these abusive tactics is preventing
generic competitors from purchasing samples at fair market rates to conduct the
safety testing that is necessary to enter the market once a branded drug
company’s patent expires.
In May, FDA Commissioner Scott Gottlieb, M.D reported that there
have been 164 reports of generic drug makers requesting assistance from the FDA
because of these delay tactics. The FDA also published two draft guidance
documents to help ensure generic drug makers get through the development and
approval processes more efficiently for drugs that have heightened safety
We applaud this first step to implement the president’s
blueprint to lower drug prices. But we must do much more.
The Creates Act is a real solution to end abusive conduct by
brand pharmaceutical companies.
Our legislation will save American taxpayers $3.8 billion
over 10 years through savings to Medicare and Medicaid, according to
the non-partisan Congressional Budget Office, and result in billions in
additional savings for American families.
This bipartisan, bicameral legislation is supported by a broad
group of U.S. senators, including its lead sponsors Sens. Patrick Leahy (D-Vt) and Chuck Grassley (R-Iowa). The bill was just overwhelmingly voted out
of the Senate Judiciary Committee by a vote of 15-6. Creates is also backed by a diverse coalition of health care
providers, patient groups, and public-interest organizations across the
political spectrum, including AARP, FreedomWorks, and Public Citizen, among
more than 80 others.
President Trump has made it a priority of his administration to
lower drug costs for all Americans by taking on conduct that impedes
competition. The Creates Act accomplishes this goal.
We call on the president and all of our colleagues to support
the Creates Act and bring lower priced prescription drugs to market for
Cicilline represents Rhode Island’s 1st District and is a member
of the Judiciary Committee. Marino represents Pennsylvania’s 10th District and is
chairman of the Judiciary Subcommittee on Regulatory Reform, Commercial and